iiinova — where your digital self keeps evolving

Reposted by 🦋Shensi Shen 慎思🦩

bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 13/07/2026

PCIF1 loss licenses antitumour immunity via cholesterol biosynthesis www.biorxiv.org/content/10.64898/20…

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 28/11/2025

⏰ Last chance to submit your abstract for Signalling Circuits in Cancer! Don’t miss your opportunity to be part of this exciting new conference topic. If your work explores oncogenic signalling, cellular communication networks, this is the perfect platform to showcase your research.

010

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 19/11/2025

Glad to share our latest perspective published on @natcomms.nature.com, trying to push #DTP research to a new frontier. Thanks to very helpful and constructive suggestions from the reviewers and editors!

022

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 12/05/2025

Our journal @oncogenesisnature.bsky.social is officially on Bluesky, follow us to know more about frontier oncological advances

011

Reposted by 🦋Shensi Shen 慎思🦩

EACR - European Association for Cancer Research @helloeacr.bsky.social · 09/05/2025

One month left to register for the 2025 Early Career Researchers Conference! In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research. Don't miss it: eacr.org/conference/e...

068

Reposted by 🦋Shensi Shen 慎思🦩

EACR - European Association for Cancer Research @helloeacr.bsky.social · 10/03/2025

The EACR stands against threats to cancer research. Protecting scientific research is vital for progress and and the development of new treatments. Read our full statement in support of our friends and colleagues in the US: eacr.org/statement-on...

04517

Reposted by 🦋Shensi Shen 慎思🦩

EACR - European Association for Cancer Research @helloeacr.bsky.social · 05/03/2025

EACR members, you're invited to join us for an in-depth discussion on securing cancer research funding! Chat with our expert guest speakers about funding opportunities, grant writing, interview strategies and more in this interactive workshop. 📅 10 March 12:00 CET us02web.zoom.us/meeting/regi...

075

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 05/03/2025

Highly recommend this nice work published on Cancer Discovery that we are honored to write a View in the context of EMT @theaacr.bsky.social

021

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 01/03/2025

It is not Nash’s game theory . Defense -attack, we do not want zero-sum game, we wanna the best attack by defense. Join this wonderful meeting in Barcelona with @helloeacr.bsky.social

020

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 07/02/2025

Wanna meet experts in drug tolerant persister cells? Learn more about the frontiers of cancer cell plasticity and minimal residual diseases, come to join us in Lyon France for this @helloeacr.bsky.social EACR conference!

010

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 31/01/2025

In the year of Snake 🐍 2025, join us @helloeacr.bsky.social in beautiful Lisboa for a prosperous year of EACR congress!

030

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 08/12/2024

MIF is the devil 😈 in detail of low intra-tumoral heterogeneous cancer that evade immune surveillances. aacrjournals.org/cancerdiscov...

010

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 04/12/2024

It was a fun to bring together reflections from researchers across various fields on inspiring cancer studies in 2024

151

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 27/11/2024

The waltz between metabolism and mRNA translation. Find out our new insight on this interaction between two essential cellular adaptive responses to stresses. authors.elsevier.com/c/1kAJt3QxxS...

000

Reposted by 🦋Shensi Shen 慎思🦩

American Association for Cancer Research (AACR) @theaacr.bsky.social · 25/11/2024

The AACR Cancer Progress Report 2024 highlights research-driven advances in cancer science and medicine. Read the Report: CancerProgressReport.org #CancerProgressReport

AACR Cancer Progress Report 2024. The Report highlights research-driven advances in cancer science and medicine. Learn more at CancerProgressReport.org

1188

Reposted by 🦋Shensi Shen 慎思🦩

EACR - European Association for Cancer Research @helloeacr.bsky.social · 20/11/2024

Did you catch our latest podcast episode? 🎧 Tune in for an insightful conversation with the authors of a recent Nature Cancer article on a novel pan-lysyl oxidase inhibitor in #PancreaticCancer. magazine.eacr.org/a-novel-pan-...

063

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 18/11/2024

Join us at the EACR-Boehringer Ingelheim virtual conference @EACR on Drugging and Regulating the MAP Kinase Pathway (11-12 February 2025) where we will assess the basic and clinical aspects of the regulation of signaling through the MAPK pathway and its role in cancer. eacr.org/conference/b...

000

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 18/11/2024

Ribosomes are heterogenous and long believed immunoribosome revealed by this study that P-Stalk ribosome responds to inflammatory cues and alert 🚨 cell immune response. www.cell.com/cell/fulltex...

cell.com

P-stalk ribosomes act as master regulators of cytokine-mediated processes

Cytokines remodel the ribosome to incorporate the P-stalk, therefore altering the translation of mRNAs involved in cytokine responses.

0305

Reposted by 🦋Shensi Shen 慎思🦩

Itai Yanai @itaiyanai.bsky.social · 17/11/2024

Too often we spend only two weeks choosing a problem and then many years trying solving it, but this limits our potential impact. A must read for PhD students: Problem choice and decision trees in science and engineering. pubmed.ncbi.nlm.nih.gov/38608651/

622868

🦋Shensi Shen 慎思🦩 @seansi.bsky.social · 17/11/2024

Shifting from X to BlueSky, first tweet 🐣 maybe our recent roadmap will let you know better what we are working on in the lab 🧫 link: www.nature.com/articles/s41...

010